To learn more about this report, request sample copy
North America remains the dominant region in the global genome engineering market and is estimated to hold 43.1% of the market share in 2024 due to a strong presence of major device manufacturers, established healthcare infrastructure, and availability of favorable reimbursement policies. The U.S. accounts for the largest share owing to presence of major players and advanced healthcare system. These players have strong distribution network across the region ensuring easy accessibility of devices. Moreover, government initiatives to spread awareness about respiratory conditions have boosted adoption rate of respiratory therapies.
The Asia Pacific region is emerging as the fastest growing market for respiratory devices. Rapidly developing healthcare infrastructure, growing geriatric population susceptible to respiratory diseases and improving access to healthcare are some key factors contributing to the high growth. China and India are expected to lead the market in the coming years supported by huge patient population, increasing healthcare expenditure, and penetration of medical insurance. Manufacturers are focusing on these developing nations by establishing local manufacturing plants to cater growing demand and ensure availability of affordable devices. Several multinational companies have also entered partnerships with local players to leverage their distribution and insights of local market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients